Literature DB >> 8530977

Selective peripheral denervation for spasmodic torticollis: is the outcome predictable?

V Braun1, H P Richter, J M Schröder.   

Abstract

If botulinum toxin fails in the treatment of cervical dystonia, selective peripheral denervation is now accepted as the best surgical option. Despite the very promising results, however, there is still a substantial group of patients who do not benefit from this procedure. Positive response to prior botulinum toxin therapy seems to be a very good predictor of outcome after selective peripheral denervation (P < 0.01). The meaning of the histological findings of the resected nerves is uncertain. Patients with histologically proven pathological nerves do not seem to benefit more than patients with histological normal ones (P < 0.30).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530977     DOI: 10.1007/bf00867420

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Spasmodic torticollis: severe compression neuropathy in rami dorsales of cervical nerves C1-6.

Authors:  J M Schröder; B Huffmann; V Braun; H P Richter
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Selective peripheral denervation in patients with spasmodic torticollis.

Authors:  V Braun; H P Richter
Journal:  Stereotact Funct Neurosurg       Date:  1991       Impact factor: 1.875

3.  Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation.

Authors:  C Bertrand; P Molina-Negro; G Bouvier; W Gorczyca
Journal:  Appl Neurophysiol       Date:  1987

4.  Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases.

Authors:  C M Bertrand
Journal:  Surg Neurol       Date:  1993-08

5.  Selective peripheral denervation for the treatment of spasmodic torticollis.

Authors:  V Braun; H P Richter
Journal:  Neurosurgery       Date:  1994-07       Impact factor: 4.654

6.  Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.

Authors:  J Jankovic; J Orman
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

7.  Botulinum toxin treatment of spasmodic torticollis.

Authors:  T J Anderson; J Rivest; R Stell; M J Steiger; H Cohen; P D Thompson; C D Marsden
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 5.344

8.  Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.

Authors:  D J Gelb; D H Lowenstein; M J Aminoff
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

  8 in total
  3 in total

1.  Prospective study of swallowing function in patients with cervical dystonia undergoing selective peripheral denervation.

Authors:  A Münchau; C D Good; S McGowan; N P Quinn; J D Palmer; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

2.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

3.  Outcome of selective ramisectomy for botulinum toxin resistant torticollis.

Authors:  B Ford; E D Louis; P Greene; S Fahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.